Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.085 USD | +9.74% | -6.75% | -37.83% |
03:25pm | Truist Securities Trims Price Target on Coherus BioSciences to $7 From $8, Maintains Buy Rating | MT |
May. 09 | Transcript : Coherus BioSciences, Inc., Q1 2024 Earnings Call, May 09, 2024 |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
COHERUS BIOSCIENCES, INC. | Bio Therapeutic Drugs | +8.95% | -6.75% | -37.83% | -57.67% | -87.63% | 218M |
- Stock Market
- Equities
- CHRS Stock
- Charts Coherus BioSciences, Inc.
- Relative Strength Chart